7 completed, 1 suspended, 1 unknown. 2 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow this condition Literature Review of Polymorphism trials Research Report on Polymorphism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Genetic Alterations Affecting the Genes Encoding the Major Enzymes of the Kynurenine Pathway on Suicidal Behavior SNP (single nucleotide polymorphism) genotyping - Tryptophan Metabolism Alterations, Polymorphism | Completed | Centre Hospitalier Universitaire de Nīmes | 849 | 2019-12-01 | 2025-02-13 | |
| Cytochrome P450 Epoxygenase Pathway Regulation of Macrophage Function Polymorphism, Lung Inflammation | Completed | National Institute of Environmental Health Sciences (NIEHS) | 20 | 2019-01-08 | 2026-10-16 | |
| Protocol PERCAF 2018 Sleep deprivation - Sleep, Caffeine | Not applicable | Completed | Institut de Recherche Biomedicale des Armees | 52 | 2018-09-02 | 2021-08-27 |
| Curcumin on NFE2L2 Gene Expression, Antioxidant Capacity and Renal Function According to rs35652124 in Diabetic Nephropathy Curcumin/NFE2L2 A>G, Placebo/NFE2L2 A>G - Chronic Kidney Diseases, Diabetes Mellitus, Type 2 | Phase 2 / Phase 3 | Unknown | Unidad de Investigacion Medica en Enfermedades Renales | 176 | 2018-08-01 | 2018-05-30 |
| Polymorphisms, Caffeine and Sleep Disorders Polymorphisms - Polymorphism, Sleep Disorder | Not applicable | Completed | Institut de Recherche Biomedicale des Armees | 1100 | 2018-01-01 | 2019-02-28 |
| Study of the Impact of VEGF Polymorphism on the Development of Renal Carcinoma in Renal Transplant Patients To study the polymorphism of the gene encoding VEGF (rs699947) as a predictive marker - Polymorphism, VEGF | Completed | Centre Hospitalier Universitaire, Amiens | 272 | 2016-10-06 | 2026-06-24 | |
| Aromatase (CYP19) Polymorphism Between AI-responsive and AI-resistant Breast Cancer in Korea Polymorphism, CYP19 | Suspended | Samsung Medical Center | 300 | 2010-06-01 | 2014-04-21 | |
| Polymorphids an mRNA Expression in Obese Genes Polymorphism, mRNA Expression | Completed | Karolinska Institutet | 50 | 2010-01-01 | 2013-08-22 | |
| CathOlic Medical Center percutAneous Coronary inTervention Registry (COACT) Drug Eluting Stent, Coronary Artery Disease | Completed | The Catholic University of Korea | 11719 | 2005-01-01 | 2022-09-07 |
Carcinoma, Renal Cell (1) · Coronary Artery Disease (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Inflammation (1) · Pneumonia (1) · Renal Insufficiency, Chronic (1) · Sleep Deprivation (1) · Sleep Wake Disorders (1)
Pathological Conditions, Signs and Symptoms (4) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Mental Disorders (2) · Nervous System Diseases (2) · Neurologic Manifestations (2) · Pathologic Processes (2) · Signs and Symptoms (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Adenocarcinoma (1) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1)
Curcumin (1) · Genotype (1) · Polymorphism, Genetic (1) · Polymorphism, Single Nucleotide (1)
Institut de Recherche Biomedicale des Armees (2) · Centre Hospitalier Universitaire de Nīmes (1) · Centre Hospitalier Universitaire, Amiens (1) · Karolinska Institutet (1) · National Institute of Environmental Health Sciences (NIEHS) (1) · Samsung Medical Center (1) · The Catholic University of Korea (1) · Unidad de Investigacion Medica en Enfermedades Renales (1)
France (4) · South Korea (2) · Mexico (1) · Spain (1) · Sweden (1) · United States (1)
Anders Thorell, Ass. prof. (1) · Darryl C Zeldin, M.D. (1) · Ki-Bae Seung, M.D.,PhD (1) · Seok Jin Nam, M.D., Ph.D. (1)
PMID 24019397, PMID 33920292, PMID 34685481, PMID 37279709, PMID 39458438, PMID 40150834, PMID 41694313